Form4insider filings, from the source

SEC Form 4 · accession 0001615774-15-001339

CALMARE THERAPEUTICS Inc · CTTC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jan 2, 2015
Accepted (ET)
Jun 3, 2015 · 11:01 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000102198

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJan 2, 2015A2,500$0.00A63,255D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Options$0.17Jan 2, 2015A10,000AJan 2, 2015Jan 2, 2020Common stock, par value $0.01 per share10,00090,000D